chr2-31525347-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000348.4(SRD5A2):​c.*849A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.132 in 226,138 control chromosomes in the GnomAD database, including 2,248 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1502 hom., cov: 32)
Exomes 𝑓: 0.13 ( 746 hom. )

Consequence

SRD5A2
NM_000348.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: -0.882

Publications

15 publications found
Variant links:
Genes affected
SRD5A2 (HGNC:11285): (steroid 5 alpha-reductase 2) This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]
SRD5A2 Gene-Disease associations (from GenCC):
  • 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 2-31525347-T-C is Benign according to our data. Variant chr2-31525347-T-C is described in ClinVar as Benign. ClinVar VariationId is 97417.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.197 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000348.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRD5A2
NM_000348.4
MANE Select
c.*849A>G
3_prime_UTR
Exon 5 of 5NP_000339.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRD5A2
ENST00000622030.2
TSL:1 MANE Select
c.*849A>G
3_prime_UTR
Exon 5 of 5ENSP00000477587.1P31213
SRD5A2
ENST00000882642.1
c.*849A>G
3_prime_UTR
Exon 6 of 6ENSP00000552701.1
SRD5A2
ENST00000882643.1
c.*849A>G
3_prime_UTR
Exon 4 of 4ENSP00000552702.1

Frequencies

GnomAD3 genomes
AF:
0.133
AC:
20246
AN:
152096
Hom.:
1492
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.200
Gnomad AMI
AF:
0.0888
Gnomad AMR
AF:
0.0945
Gnomad ASJ
AF:
0.269
Gnomad EAS
AF:
0.106
Gnomad SAS
AF:
0.0983
Gnomad FIN
AF:
0.0986
Gnomad MID
AF:
0.193
Gnomad NFE
AF:
0.104
Gnomad OTH
AF:
0.132
GnomAD4 exome
AF:
0.129
AC:
9557
AN:
73924
Hom.:
746
Cov.:
0
AF XY:
0.130
AC XY:
4438
AN XY:
34108
show subpopulations
African (AFR)
AF:
0.212
AC:
738
AN:
3480
American (AMR)
AF:
0.0929
AC:
208
AN:
2238
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
1207
AN:
4690
East Asian (EAS)
AF:
0.139
AC:
1471
AN:
10576
South Asian (SAS)
AF:
0.0905
AC:
59
AN:
652
European-Finnish (FIN)
AF:
0.148
AC:
8
AN:
54
Middle Eastern (MID)
AF:
0.213
AC:
97
AN:
456
European-Non Finnish (NFE)
AF:
0.109
AC:
4969
AN:
45588
Other (OTH)
AF:
0.129
AC:
800
AN:
6190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
414
828
1242
1656
2070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.133
AC:
20289
AN:
152214
Hom.:
1502
Cov.:
32
AF XY:
0.132
AC XY:
9793
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.201
AC:
8338
AN:
41522
American (AMR)
AF:
0.0945
AC:
1446
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
933
AN:
3470
East Asian (EAS)
AF:
0.106
AC:
549
AN:
5174
South Asian (SAS)
AF:
0.0990
AC:
478
AN:
4830
European-Finnish (FIN)
AF:
0.0986
AC:
1046
AN:
10606
Middle Eastern (MID)
AF:
0.194
AC:
57
AN:
294
European-Non Finnish (NFE)
AF:
0.104
AC:
7082
AN:
68000
Other (OTH)
AF:
0.132
AC:
279
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
878
1755
2633
3510
4388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.121
Hom.:
3813
Bravo
AF:
0.138
Asia WGS
AF:
0.105
AC:
366
AN:
3476

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency (1)
-
-
1
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.55
DANN
Benign
0.76
PhyloP100
-0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9332975; hg19: chr2-31750417; API